Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00176228 · ClinicalTrials.gov registry record · Phase 2
Lamotrigine Monotherapy in Pediatric Bipolar Disorder
A Phase 2 study, sponsored by University of Illinois at Chicago.
- Completed
- Registry status
- Phase 2
- Development phase
- 48
- Enrollment target
NCT00176228 is a Phase 2 study that has completed, run by University of Illinois at Chicago. The registered enrollment target is 48 participants.
The verdict
NCT00176228, a Phase 2 study, has completed, sponsored by University of Illinois at Chicago.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 48 participants
- Enrollment target
Study Summary
There are two purposes for this project. Study 1 is intended to study the safety and efficacy of Lamotrigine in stabilizing the mood in all phases of pediatric bipolar disorder (Phases: mixed, manic, hypomanic, or depressed episodes) in 8-17 year old children. These children and adolescents must be treatment resistant (who failed on two adequate trials of mood stabilizing medications) to qualify for this study. Study 2 is aimed at examining brain activity and/or dysfunction before lamotrigine treatment, and to look for any alteration after lamotrigine treatment. Brain systems associated with attention and emotional processing will targeted.
Interventions
- DRUG Lamotrigine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2004-02 |
| Est. Completion | 2008-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00176228
The ClinicalTrials.gov registry entry for NCT00176228 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lamotrigine is the first listed.
NCT00176228 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00176228 about?
NCT00176228 is a clinical study titled "Lamotrigine Monotherapy in Pediatric Bipolar Disorder". There are two purposes for this project. Study 1 is intended to study the safety and efficacy of Lamotrigine in stabilizing the mood in all phases of pediatric bipolar disorder (Phases: mixed, manic, hypomanic, or depressed episodes) in 8-17 year old children. These children and adolescents must be ...
What is the current status of trial NCT00176228?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 48 participants. The study started on 2004-02. Estimated completion is 2008-01.
What interventions are being tested in trial NCT00176228?
The interventions under investigation include: Lamotrigine (DRUG).
Who is sponsoring clinical trial NCT00176228?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.